StockNews.com Upgrades Phibro Animal Health (NASDAQ:PAHC) to “Strong-Buy”

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a buy rating to a strong-buy rating in a research report released on Saturday morning.

PAHC has been the subject of a number of other research reports. Morgan Stanley increased their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Barclays upped their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research report on Tuesday, November 12th. Finally, JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target for the company. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $20.50.

Phibro Animal Health Stock Performance

NASDAQ PAHC opened at $20.61 on Friday. Phibro Animal Health has a twelve month low of $10.03 and a twelve month high of $25.98. The stock has a market cap of $834.77 million, a P/E ratio of 47.93, a PEG ratio of 0.58 and a beta of 0.53. The company’s 50-day simple moving average is $23.01 and its 200 day simple moving average is $21.01. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th were paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.33%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health’s payout ratio is presently 111.63%.

Hedge Funds Weigh In On Phibro Animal Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Brandes Investment Partners LP increased its position in shares of Phibro Animal Health by 1.2% in the 2nd quarter. Brandes Investment Partners LP now owns 2,405,629 shares of the company’s stock valued at $40,521,000 after buying an additional 29,071 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in Phibro Animal Health by 5.7% in the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock valued at $13,005,000 after acquiring an additional 42,086 shares during the period. Acadian Asset Management LLC grew its stake in Phibro Animal Health by 6.3% in the second quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock valued at $12,027,000 after acquiring an additional 42,299 shares during the period. Dana Investment Advisors Inc. increased its holdings in shares of Phibro Animal Health by 17.2% in the second quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock worth $8,619,000 after acquiring an additional 75,546 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Phibro Animal Health by 5.7% during the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock worth $11,430,000 after purchasing an additional 27,201 shares during the period. 99.34% of the stock is owned by institutional investors.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.